Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 1
2013 1
2014 1
2017 2
2018 3
2019 2
2020 5
2021 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 Pandemic-Adapted Radiotherapy Guidelines: Are They Really Followed?
Galofaro E, Malizia C, Ammendolia I, Galuppi A, Guido A, Ntreta M, Siepe G, Tolento G, Veraldi A, Scirocco E, Arcelli A, Buwenge M, Ferioli M, Zamagni A, Strigari L, Cammelli S, Morganti AG. Galofaro E, et al. Among authors: ntreta m. Curr Oncol. 2021 Aug 27;28(5):3323-3330. doi: 10.3390/curroncol28050288. Curr Oncol. 2021. PMID: 34590595 Free PMC article.
Pros-IT CNR: an Italian prostate cancer monitoring project.
Noale M, Maggi S, Artibani W, Bassi PF, Bertoni F, Bracarda S, Conti GN, Corvò R, Gacci M, Graziotti P, Magrini SM, Maurizi Enrici R, Mirone V, Montironi R, Muto G, Pecoraro S, Porreca A, Ricardi U, Tubaro A, Zagonel V, Zattoni F, Crepaldi G; Pros-IT CNR study group. Noale M, et al. Aging Clin Exp Res. 2017 Apr;29(2):165-172. doi: 10.1007/s40520-017-0735-6. Epub 2017 Feb 24. Aging Clin Exp Res. 2017. PMID: 28236267
The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study.
Gacci M, Greco I, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti GN, Corvò R, DE Nunzio C, Fusco F, Graziotti P, Maggi S, Magrini SM, Mirone V, Montironi R, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Salonia A, Simonato A, Serni S, Tubaro A, Zagonel V, Crepaldi G; Pros-IT CNR Study Group. Gacci M, et al. Minerva Urol Nephrol. 2022 Feb;74(1):38-48. doi: 10.23736/S2724-6051.20.03925-9. Epub 2020 Nov 17. Minerva Urol Nephrol. 2022. PMID: 33200896 Free article.
Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study.
Buwenge M, Deodato F, Macchia G, Siepe G, Zhao X, Valicenti RK, Cilla S, Alitto AR, Ntreta M, Bisello S, Mantini G, Valentini V, Morganti AG, Cammelli S. Buwenge M, et al. Among authors: ntreta m. Anticancer Res. 2019 Nov;39(11):6373-6378. doi: 10.21873/anticanres.13850. Anticancer Res. 2019. PMID: 31704870
Hypofractionated Postoperative IMRT in Prostate Carcinoma: A Phase I/II Study.
Macchia G, Siepe G, Capocaccia I, Nguyen NP, Schiavina R, Cammelli S, Guerri S, Arcelli A, Buwenge M, Ntreta M, Cilla S, Valentini V, Deodato F, Morganti AG. Macchia G, et al. Among authors: ntreta m. Anticancer Res. 2017 Oct;37(10):5821-5828. doi: 10.21873/anticanres.12025. Anticancer Res. 2017. PMID: 28982907 Clinical Trial.
Unraveling the safety of adjuvant radiotherapy in prostate cancer: impact of older age and hypofractionated regimens on acute and late toxicity - a multicenter comprehensive analysis.
Buwenge M, Macchia G, Cavallini L, Cortesi A, Malizia C, Bianchi L, Ntreta M, Arcelli A, Capocaccia I, Natoli E, Cilla S, Cellini F, Tagliaferri L, Strigari L, Cammelli S, Schiavina R, Brunocilla E, Morganti AG, Deodato F. Buwenge M, et al. Among authors: ntreta m. Front Oncol. 2023 Dec 13;13:1281432. doi: 10.3389/fonc.2023.1281432. eCollection 2023. Front Oncol. 2023. PMID: 38192625 Free PMC article.
How smart is artificial intelligence in organs delineation? Testing a CE and FDA-approved Deep-Learning tool using multiple expert contours delineated on planning CT images.
Strolin S, Santoro M, Paolani G, Ammendolia I, Arcelli A, Benini A, Bisello S, Cardano R, Cavallini L, Deraco E, Donati CM, Galietta E, Galuppi A, Guido A, Ferioli M, Laghi V, Medici F, Ntreta M, Razganiayeva N, Siepe G, Tolento G, Vallerossa D, Zamagni A, Morganti AG, Strigari L. Strolin S, et al. Among authors: ntreta m. Front Oncol. 2023 Mar 2;13:1089807. doi: 10.3389/fonc.2023.1089807. eCollection 2023. Front Oncol. 2023. PMID: 36937399 Free PMC article.
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study.
Palumbo C, Bruni A, Antonelli A, Artibani W, Bassi P, Bertoni F, Borghetti P, Bracarda S, Cicchetti A, Corvò R, Gacci M, Ingrosso G, Magrini SM, Maruzzo M, Mirone V, Montironi R, Muto G, Noale M, Porreca A, Russi E, Triggiani L, Tubaro A, Valdagni R, Maggi S, Conti GN; Pros-IT CNR Study Group. Palumbo C, et al. Minerva Urol Nephrol. 2022 Feb;74(1):11-20. doi: 10.23736/S2724-6051.20.04032-1. Epub 2021 Jan 13. Minerva Urol Nephrol. 2022. PMID: 33439570 Free article.
19 results